We have previously shown that CCDC134 as a potential member of the γc cytokine family significantly augmented the activation, proliferation, and cytotoxicity of CD8+ T cells in vitro and recombinant hCCDC134 protein exerted anti-tumor activity in a CD8+ T cell-dependent manner in vivo (17). This evidence concerns the gene CD8A and neoplasm.